Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRent ExpenseShares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

National Healthcare (NHC) EBIAT (2016 - 2025)

National Healthcare's EBIAT history spans 16 years, with the latest figure at $25.2 million for Q4 2025.

  • For Q4 2025, EBIAT rose 303.75% year-over-year to $25.2 million; the TTM value through Dec 2025 reached $122.6 million, up 19.75%, while the annual FY2025 figure was $122.6 million, 20.1% up from the prior year.
  • EBIAT reached $25.2 million in Q4 2025 per NHC's latest filing, down from $41.0 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $105.3 million in Q2 2021 to a low of -$3.5 million in Q3 2021.
  • Average EBIAT over 5 years is $22.5 million, with a median of $18.8 million recorded in 2021.
  • Peak YoY movement for EBIAT: plummeted 127.6% in 2021, then soared 636.56% in 2023.
  • A 5-year view of EBIAT shows it stood at $16.3 million in 2021, then plummeted by 65.77% to $5.6 million in 2022, then soared by 401.7% to $28.0 million in 2023, then tumbled by 77.69% to $6.2 million in 2024, then skyrocketed by 303.75% to $25.2 million in 2025.
  • Per Business Quant, the three most recent readings for NHC's EBIAT are $25.2 million (Q4 2025), $41.0 million (Q3 2025), and $24.1 million (Q2 2025).